Clinical trial programme with new c-Met inhibitor for kidney cancer initiated in Australia and New Zealand
CBT Pharmaceuticals (a US and China-based biopharmaceutical company) announced the [...]
CBT Pharmaceuticals (a US and China-based biopharmaceutical company) announced the [...]
A recent study published in European Urology Focus reports that the [...]
Immune-related adverse events (irAEs) are side effects that can develop [...]
A clinical trial looking at the combination of avelumab plus [...]
The European Association of Urology (EAU) Renal Cell Cancer Guidelines [...]
A recent study published in The Journal of Urology this month [...]
This blog starts with the results of a survey of [...]
A 10-year study presented at an international medical conference in [...]
A recent article in Annals of Oncology reports new patient-reported outcomes [...]
New research, published in the journal Nature Methods, describes a [...]